218 related articles for article (PubMed ID: 24846705)
1. Return to intended oncologic treatment (RIOT): a novel metric for evaluating the quality of oncosurgical therapy for malignancy.
Aloia TA; Zimmitti G; Conrad C; Gottumukalla V; Kopetz S; Vauthey JN
J Surg Oncol; 2014 Aug; 110(2):107-14. PubMed ID: 24846705
[TBL] [Abstract][Full Text] [Related]
2. Detours on the Road to Recovery: What Factors Delay Readiness to Return to Intended Oncologic Therapy (RIOT) After Liver Resection for Malignancy?
Lillemoe HA; Marcus RK; Kim BJ; Narula N; Davis CH; Aloia TA
J Gastrointest Surg; 2019 Dec; 23(12):2362-2371. PubMed ID: 30809785
[TBL] [Abstract][Full Text] [Related]
3. Return to Intended Oncologic Treatment (RIOT) in Resected Gastric Cancer Patients.
Ramos MFKP; de Castria TB; Pereira MA; Dias AR; Antonacio FF; Zilberstein B; Hoff PMG; Ribeiro U; Cecconello I
J Gastrointest Surg; 2020 Jan; 24(1):19-27. PubMed ID: 31745892
[TBL] [Abstract][Full Text] [Related]
4. Minimally Invasive Resection of Colorectal Cancer Liver Metastases Leads to an Earlier Initiation of Chemotherapy Compared to Open Surgery.
Tohme S; Goswami J; Han K; Chidi AP; Geller DA; Reddy S; Gleisner A; Tsung A
J Gastrointest Surg; 2015 Dec; 19(12):2199-206. PubMed ID: 26438480
[TBL] [Abstract][Full Text] [Related]
5. Impact of neoadjuvant chemotherapy on short-term outcomes after simple and complex minimally invasive minor hepatectomy for colorectal liver metastases: A propensity-score matched and coarsened exact matched study.
Hoogteijling TJ; Abu Hilal M; Zimmitti G; Aghayan DL; Wu AGR; Cipriani F; Gruttadauria S; Scatton O; Long TCD; Herman P; Marino MV; Mazzaferro V; Chiow AKH; Sucandy I; Ivanecz A; Choi SH; Lee JH; Gastaca M; Vivarelli M; Giuliante F; Ruzzenente A; Yong CC; Yin M; Fondevila C; Efanov M; Morise Z; Di Benedetto F; Brustia R; Dalla Valle R; Boggi U; Geller D; Belli A; Memeo R; Mejia A; Park JO; Rotellar F; Choi GH; Robles-Campos R; Wang X; Sutcliffe RP; Pratschke J; Tang CN; Chong CCN; D'Hondt M; Monden K; Lopez-Ben S; Kingham TP; Ferrero A; Ettorre GM; Cherqui D; Liang X; Soubrane O; Wakabayashi G; Troisi RI; Han HS; Cheung TT; Sugioka A; Dokmak S; Chen KH; Liu R; Fuks D; Zhang W; Aldrighetti L; Edwin B; Goh BKP;
Eur J Surg Oncol; 2024 Jun; 50(6):108309. PubMed ID: 38626588
[TBL] [Abstract][Full Text] [Related]
6. Perioperative and oncologic outcomes of minimally invasive liver resection for colorectal metastases: A case-control study of 130 patients.
Karagkounis G; Akyuz M; Guerron AD; Yazici P; Aucejo FN; Quintini C; Miller CM; Vogt DP; Fung JJ; Berber E
Surgery; 2016 Oct; 160(4):1097-1103. PubMed ID: 27486002
[TBL] [Abstract][Full Text] [Related]
7. Severe Preoperative Symptoms Delay Readiness to Return to Intended Oncologic Therapy (RIOT) After Liver Resection.
Lillemoe HA; Marcus RK; Kim BJ; Narula N; Davis CH; Shi Q; Wang XS; Aloia TA
Ann Surg Oncol; 2019 Dec; 26(13):4548-4555. PubMed ID: 31414293
[TBL] [Abstract][Full Text] [Related]
8. Minimally invasive liver surgery for metastases from colorectal cancer: oncologic outcome and prognostic factors.
Topal B; Tiek J; Fieuws S; Aerts R; Van Cutsem E; Roskams T; Prenen H
Surg Endosc; 2012 Aug; 26(8):2288-98. PubMed ID: 22311303
[TBL] [Abstract][Full Text] [Related]
9. Faster Return to Intended Oncologic Treatment (RIOT) After Trisectionectomy Does Not Translate to Better Outcomes.
Baimas-George M; Watson M; Pickens RC; Sulzer J; Murphy KJ; Ocuin L; Baker E; Martinie J; Iannitti D; Vrochides D
Am Surg; 2021 Feb; 87(2):309-315. PubMed ID: 32936007
[TBL] [Abstract][Full Text] [Related]
10. Preoperative bevacizumab does not significantly increase postoperative complication rates in patients undergoing hepatic surgery for colorectal cancer liver metastases.
Kesmodel SB; Ellis LM; Lin E; Chang GJ; Abdalla EK; Kopetz S; Vauthey JN; Rodriguez-Bigas MA; Curley SA; Feig BW
J Clin Oncol; 2008 Nov; 26(32):5254-60. PubMed ID: 18854565
[TBL] [Abstract][Full Text] [Related]
11. Minimally invasive liver resection for metastatic colorectal cancer: a multi-institutional, international report of safety, feasibility, and early outcomes.
Nguyen KT; Laurent A; Dagher I; Geller DA; Steel J; Thomas MT; Marvin M; Ravindra KV; Mejia A; Lainas P; Franco D; Cherqui D; Buell JF; Gamblin TC
Ann Surg; 2009 Nov; 250(5):842-8. PubMed ID: 19806058
[TBL] [Abstract][Full Text] [Related]
12. Preoperative chemotherapy and the risk of hepatotoxicity and morbidity after liver resection for metastatic colorectal cancer: a single institution experience.
Wolf PS; Park JO; Bao F; Allen PJ; DeMatteo RP; Fong Y; Jarnagin WR; Kingham TP; Gönen M; Kemeny N; Shia J; D'Angelica MI
J Am Coll Surg; 2013 Jan; 216(1):41-9. PubMed ID: 23041049
[TBL] [Abstract][Full Text] [Related]
13. Adjuvant chemotherapy with FOLFOX for primary colorectal cancer is associated with increased somatic gene mutations and inferior survival in patients undergoing hepatectomy for metachronous liver metastases.
Andreou A; Kopetz S; Maru DM; Chen SS; Zimmitti G; Brouquet A; Shindoh J; Curley SA; Garrett C; Overman MJ; Aloia TA; Vauthey JN
Ann Surg; 2012 Oct; 256(4):642-50. PubMed ID: 22968062
[TBL] [Abstract][Full Text] [Related]
14. Laparoscopic versus open two-stage hepatectomy for bilobar colorectal liver metastases: A bi-institutional, propensity score-matched study.
Okumura S; Goumard C; Gayet B; Fuks D; Scatton O
Surgery; 2019 Dec; 166(6):959-966. PubMed ID: 31395397
[TBL] [Abstract][Full Text] [Related]
15. Selective resection of colorectal liver metastases.
Tamandl D; Gruenberger B; Herberger B; Schoppmann S; Bodingbauer M; Schindl M; Puhalla H; Fleischmann E; Schima W; Jakesz R; Laengle F; Gruenberger T
Eur J Surg Oncol; 2007 Mar; 33(2):174-82. PubMed ID: 17046194
[TBL] [Abstract][Full Text] [Related]
16. Long-term results of two-stage hepatectomy for irresectable colorectal cancer liver metastases.
Wicherts DA; Miller R; de Haas RJ; Bitsakou G; Vibert E; Veilhan LA; Azoulay D; Bismuth H; Castaing D; Adam R
Ann Surg; 2008 Dec; 248(6):994-1005. PubMed ID: 19092344
[TBL] [Abstract][Full Text] [Related]
17. Minimally invasive management of the entire treatment sequence in patients with stage IV colorectal cancer: a propensity-score weighting analysis.
Goumard C; Nancy You Y; Okuno M; Kutlu O; Chen HC; Simoneau E; Vega EA; Chun YS; David Tzeng C; Eng C; Vauthey JN; Conrad C
HPB (Oxford); 2018 Dec; 20(12):1150-1156. PubMed ID: 30005993
[TBL] [Abstract][Full Text] [Related]
18. Laparoscopic hepatectomy significantly shortens the time to postoperative chemotherapy in patients undergoing major hepatectomies.
Mbah N; Agle SC; Philips P; Egger ME; Scoggins CR; McMasters KM; Martin RCG
Am J Surg; 2017 Jun; 213(6):1060-1064. PubMed ID: 28173934
[TBL] [Abstract][Full Text] [Related]
19. Impact of Neoadjuvant Chemotherapy on the Postoperative Outcomes of Patients Undergoing Liver Resection for Colorectal Liver Metastases: A Population-Based Propensity-Matched Analysis.
Wiseman JT; Guzman-Pruneda F; Xourafas D; Chun YS; Ejaz A; Tsung A; Pawlik TM; Cloyd JM
J Am Coll Surg; 2019 Jul; 229(1):69-77.e2. PubMed ID: 30905856
[TBL] [Abstract][Full Text] [Related]
20. Modern trends in minimally invasive versus open hepatectomy for colorectal liver metastasis: an analysis of ACS-NSQIP.
Carpenter EL; Thomas KK; Adams AM; Valdera FA; Chick RC; Kemp Bohan PM; Spitzer HV; Clifton GT; Bader JO; Nelson DW; Vreeland TJ
Surg Endosc; 2023 Jul; 37(7):5591-5602. PubMed ID: 36344895
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
